Siringocistoadenoma papilífero de localización inusual

-A A +A
Reporte de caso
Rev Asoc Colomb Dermatol. 2015; 23: 1 (Enero-Marzo), 73-76

Siringocistoadenoma papilífero de localización inusual

Unusual location of a syringocystadenoma papilliferum
Autor(es): 
Nathalie Quiroz
nathaliequiroz@hotmail.com
Médica, residente de Dermatología y Cirugía Dermatológica, Universidad del Valle, Cali, Colombia.
José H. Bravo
Médico, residente de Anatomía Patológica y Patología Clínica, Universidad del Valle, Cali, Colombia.
Ricardo Rueda
Médico dermatopatólogo; docente, Universidad del Valle, Cali, Colombia.
Resumen: 

El siringocistoadenoma papilífero es un tumor benigno de los anexos que ocurre en la infancia y la adolescencia. Tiene una presentación clínica variable con lesiones tipo pápula, placas alopécicas o nódulos. Dada la presentación inespecífica, la histopatología es necesaria para confirmar el diagnóstico de la lesión. Puede transformarse en lesiones nodulares o verrugosas en la pubertad. Más del 75 % de los casos se reportan en la cabeza y el cuello; el 40 % se asocia con nevus sebáceo.

Se reporta el caso de un paciente con un siringocistoadenoma papilífero con diferenciación apocrina, ubicado en el tobillo, localización inusual; solo hay tres casos previamente reportados en la literatura científica revisada, localizados en las piernas, sin reportes previos en Latinoamérica de este tumor en esta localización.

Palabras clave: 
siringocistoadenoma papilífero, pierna, lesiones verrugosas, tobillo, tumores benignos

Summary: 

The syringocystadenoma papilliferum is an adnexal benign tumor that occurs in childhood and adolescence. Clinical presentation is variable consisting of papules, alopecic plaques or nodules and, therefore, histopathology is required to confirm the diagnosis. The lesions may undergo nodular or verrucous transformation at puberty. Over 75% of cases occur in the head and neck, and 40% are associated with the presence of sebaceous nevi.

We report an unusual case of a syringocystadenoma papilliferum in the ankle with apocrine differentiation, with only 3 cases previously reported in the literature that were located in the leg and no prior reports in Latin America.

Key words: 
Syringocystadenoma papilliferum, leg, verrucous lesions, ankle, benign neoplasm
PDF del articulo

Referencias

  1. Stokes JH. A clinic-pathologic study of an unusual cutaneous neoplasm combining a naevus syringadenomatous papilliferus and a granuloma. J Cutan Dis.1917;35:411-9.
  2. Yamamoto O, Doi Y, Hamada T, Hisaoka M, Sasaguri Y. An immunohistochemical and ultrastructural study of syringocystadenoma papilliferum. Br J Dermatol. 2002;147:936-45.
  3. Xu D, Bi T, Lan H, Yu W, Wang W, Cao F, Jin K. Syringocystadenoma papilliferum in the right lower abdomen: A case report and review of literature. Onco Targets Ther. 2013;6:233-6.
  4. Mammino JJ, Vidmar DA. Syringocystadenoma papilliferum. Int J Dermatol. 1991;30:763-6. 
  5. Böni R, Xin H, Hohl D, Panizzon R, Burg G. Syringocystadenoma papilliferum: A study of potential tumor suppressor genes. Am J Dermatopathol. 2001;23:87-9. 
  6. Karg E, Korom I, Varga E, Ban G, Turi S. Congenital syringocystadenoma papilliferum. Pediatr Dermatol. 2008;25:132-3.
  7. Rao VA, Kamath GG, Kumar A. An unusual case of syringocystadenoma papilliferum on the eyelid. Indian J Ophthalmol. 1996;44:168-9.
  8. Rammeh-Rommani S, Fezaa B, Chelbi E, Kamoun MR, Baltagi Ben Jilani S, Zermani R. Syringocystadenoma papilliferum at an unusual site. Ann Dermatol Venereol. 2006;133:301-2.
  9. Arias D, Castellano V, Córdoba S, Miñano R, Martínez D, Borbujoa J. Siringocistoadenoma papilífero de presentación atípica. Actas Dermosifiliogr. 2006;97:647-9.
  10. De Bliek JP, Starink TM. Multiple linear syringocystadenoma papilliferum. J Eur Acad Dermatol Venereol. 1999;12:74-6.
  11. Patterson JW, Straka BF, Wick MR. Linear syringocystadenoma papilliferum of the thigh. J Am AcadDermatol. 2001;45:139-41.
  12. Arai Y, Kusakabe H, Kiyokane K. A case of syringocystadenocarcinoma papilliferum in situ occurring partially in syringocystadenoma papilliferum. J Dermatol. 2003;30:146-50.
  13. Malhotra P, Singh A, Ramesh V. Syringocystadenoma papilliferum on the thigh: An unusual location. Indian J Dermatol Venereol Leprol 2009;75:170-2.
  14. Khurana V, Mehta R, Chaudhary D, Pant L. A case of syringocystadenoma papilliferum on the lower leg: A rare location. Indian J Dermatol. 2013;58:405.
  15. Helwig EB, Hackney VC. Syringadenoma papilliferum, lesions with and without naevus sebaceous and basal cell carcinoma. AMA Arch Derm. 1955;71:361-72.
  16. Skelton HG 3rd, Smith KJ, Young D, Lupton GP. Condyloma acuminatum associated with syringocystadenoma papilliferum. Am J Dermatopathol. 1994;16:628-30.
  17. Premlatha S, Rao NR, Yesudian P, Razack A, Zahra A. Segmental syringocystadenoma papilliferum in an unusual location. Int J Dermatol 1985;24:520-1.
  18. Bondi R, Urso C. Syringocystadenocarcinoma papilliferum. Histopathology. 1996;28:475-7.
  19. Rammeh-Rommani S, Fezaa B, Chelbi E, Kammoun M, Ben Zilani S, Zermani R. Syringocystadenoma papilliferum: Report of 8 cases. Pathologica. 2006;98:178-80.
  20. Penneys NS, Nadji M, Morales A. Carcinoembryonic antigen in benign sweat gland tumors. Arch Dermatol.1982;118:225-7. 
  21. Maiorana A, Nigrisoli E, Papotti M. Immunohistochemical markers of sweat gland tumors. J Cutan Pathol. 1986;13:187-96.
  22. Nizuma K. Syringocystadenoma papilliferum developed from giant comedo: A case report. Tokai J Exp Clin Med 1986;11:47-50.
  23. Pinkus H. Life history of naevus syringocystadenoma papilliferum. Arch Dermatol Syph. 1954;69:305-22.
  24. Ndiaye B, Kane A, Develoux M, Dieng MT, Saccharin C. Syringocystadenoma papilliferum. A case located on the knee. Ann Dermatol Venereol. 1994;121:323-4. 
  25. Townsend TC, Bowen AR, Nobuhara KK. Syringocystadenoma papilliferum: An unusual cutaneous lesion in a pediatric patient. J Pediatr. 2004;145:131-3.
  26. Yamamoto T, Mamada A. Syringocystadenoma papilliferum arising on the thigh without connection to the overlying epidermis. Am J Dermatopathol. 2008;30:84-5.
  27. Yoshii N, Kanekura T, Setoyama M, Kanzaki T. Syringocystadenoma papilliferum: Report of the first case on the lower leg. J Dermatol. 2004;31:939-42.
  28. Jordan JA, Brown OE, Biavati MJ, Manning SC. Congenital syringocystadenoma papilliferum of the ear and neck treated with the CO2 laser. Int J Pediatr Otorhinolaryngol. 1996;38:81-7.
     
Verrucous nodule on the leg of a 55 year old man
Rev Asoc Colomb Dermatol. 2015; 23: 1 (Enero-Marzo), 19-20 / 80-82.
Make your own diagnosis
Rev Asoc Colomb Dermatol. 2015; 23: 1 (Enero-Marzo), 18 / 77-79.
Unusual location of a syringocystadenoma papilliferum
Rev Asoc Colomb Dermatol. 2015; 23: 1 (Enero-Marzo), 73-76
Rupioid psoriasis, a rare variant of psoriasis
Rev Asoc Colomb Dermatol. 2015; 23: 1 (Enero-Marzo), 69-72
Immunopathogenic aspects of IL-17 in psoriasis: a novel therapeutic target
Immunopathogenic aspects of IL-17 in psoriasis: a novel therapeutic target
Nail biopsy techniques
Rev Asoc Colomb Dermatol. 2015; 23: 1 (Enero-Marzo), 49-60
Omalizumab in Dermatology
Rev Asoc Colomb Dermatol. 2015; 23: 1 (Enero-Marzo), 39-48
Metabolic syndrome in patients with psoriasis, Centro Dermatológico CES Sabaneta, April-June 2012
Rev Asoc Colomb Dermatol. 2015; 23: 1 (Enero-Marzo), 30-38
Biosimilars update, a reflection on regulations in Colombia about biological and biosimilar medicines
Rev Asoc Colomb Dermatol. 2015; 23: 1 (Enero-Marzo), 23-29
Make your own diagnosis
Rev Asoc Colomb Dermatol. 2015; 23: 1 (Enero-Marzo), 18 / 77-79

PATROCINADORES PRINCIPALES

  • MEDIVELIUS
  • SIEGFRIED
  • MEDIHEALTH
  • SESDERMA
  • PERCOS
  • MD FARMACIA MAGISTRAL
  • EPIDERMIQUE
  • ISDIN
  • GALDERMA